Press Release Cincinnati Children’s Activated as the Seventh Qualified Treatment Center for ZEVASKYN® Abeona Therapeutics Inc. · Jul 21
Press Release Rezolute to Participate in the BTIG Virtual Biotechnology Conference Rezolute, Inc. · Jul 21
Press Release Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly Novo Nordisk A/S · Jul 21
Press Release EU Proposes to Embed CORSIA into Law Through 2035 as Base Carbon’s Rwanda Inventory Becomes Fully CORSIA-Eligible Base Carbon Inc. · Jul 21
Press Release Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026 ALTERITY THERAPEUTICS LIMITED · Jul 21
Press Release Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication Kraig Biocraft Laboratories · Jul 21
Press Release American Battery Materials Announces Anticipated Uplisting to the NYSE American Stock Exchange American Battery Materials, Inc. · Jul 21
Press Release Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types Applied Biologics · Jul 21
Press Release R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis R1 Therapeutics · Jul 21
Press Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Vicor Corporation · Jul 21
Press Release Aebi Schmidt Group declares quarterly dividend of $0.025 per share and will announce second quarter 2026 earnings on August 13, 2026 Aebi Schmidt Group / Aebi Schmidt Holding AG · Jul 21